{"name":"Andarix Pharmaceuticals","slug":"andarix-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNQWg4SUR5bUFDRjVaXzVTQThtOWl6WEVhSjBkYlo4OUhaWFY5QTJ4eU9HTE40Z1k5eFlGYTlvNDlYMkYxLTZHRzVZbGFwQ1hkVW9hMUVlZEUtTno2ajR6VzRWcmNhSkdWaXpCcnNyMUNrSG40NGc5Y2ZrOXNkYmtCRzFvVHFibjhnWmYzNnRTZFluTlVTYkF1WjFR?oc=5","date":"2024-10-28","type":"trial","source":"Clinical Trials Arena","summary":"Social media engagement boosts rare disease outreach - Clinical Trials Arena","headline":"Social media engagement boosts rare disease outreach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQVzdMMWJULWVjYzhsdExRZmRRWHFHTFB3U1RGd3JtQWVXSEt1bWdWbElFRE5BXzlYZ1VZYWxDYmJGaTR5Q2J3STVRV2piTHluNmVNN2N4MUVJWTMyWlFNa2tSeUgzeFVCR0pvb0FPTWJHMVBQaU1iandhalJ1UGJhT3Y5X3EzbU5VcHBXNGVzNVF5RnFUejZpNHp2d0FTcVlQeXBDRE5wS21xVkgxVmg1eTY0ODZIeUU1Y2NVM1hyZFNlLUxqUVBQcDBzY21tNDJwNGtQNWMtSGV5WVc1Tkl0Y1hUczNuQUIxMnVMTA?oc=5","date":"2024-10-07","type":"pipeline","source":"GlobeNewswire","summary":"Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight - GlobeNewswire","headline":"Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}